I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 30% ± 11% | |
| plasmacytoid dendritic cell | 6 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 17% ± 2% | |
| classical monocyte | 5 studies | 20% ± 4% | |
| oligodendrocyte | 5 studies | 23% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| non-classical monocyte | 3 studies | 24% ± 5% | |
| endothelial cell | 3 studies | 24% ± 5% | |
| glutamatergic neuron | 3 studies | 28% ± 9% | |
| natural killer cell | 3 studies | 17% ± 1% | |
| basal cell | 3 studies | 28% ± 12% | |
| astrocyte | 3 studies | 25% ± 2% |
